EA
MPT

Evolution Advisers’s Medical Properties Trust MPT Stock Holding History

Evolution Advisers’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+55
New +$273 ﹤0.01% 623

Other funds holding MPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Evolution Advisers's MPT Position: Q2 2026 in Review

Evolution Advisers opened a new position in Medical Properties Trust (MPT) in Q2 2026: 55 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #623 among its holdings.

487 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Evolution Advisers held 55 shares of Medical Properties Trust worth $0 as of Q2 2026.
  • Medical Properties Trust was a new Evolution Advisers position in Q2 2026.
  • Medical Properties Trust made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #623 holding.
  • 487 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.